Skip to content

Study on effectiveness and safety of Kudingcha extract in intervention of adult overweight population

Study on effectiveness and safety of Kudingcha extract in intervention of adult overweight population

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500103427
Enrollment
Unknown
Registered
2025-05-29
Start date
2023-09-30
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight

Interventions

Placebo control group:The volunteers in this group were given dietary guidance, to maintain three regular meals, to ensure at least 2000ml of water per day, to abstain from alcohol, not to drink other
Kudingcha extract low-dose intervention group:The volunteers in this group were given dietary guidance, to maintain three regular meals, to ensure at least 2000ml of water per day, to abstain from alc
Kudingcha extract high-dose intervention group:The volunteers in this group were given dietary guidance, to maintain three regular meals, to ensure at least 2000ml of water per day, to abstain from al

Sponsors

College of Public Health, Medical College, Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the diagnostic criteria (the diagnostic criteria of the Chinese Resident Expert Consensus on Obesity Prevention and Control: overweight is defined as 24 kg/m^2 <= body mass index (BMI) < 27.9 kg/m^2); (2) Age 18-65 years old (including the threshold), male or female; (3) Did not participate in clinical research, or after participating in clinical research has stopped the drug elution for more than 6 months; (4) Be able to understand the procedures and methods of the study, be willing and able to maintain a stable diet and exercise lifestyle during the study period, and voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: (1) Those who do not meet the above inclusion criteria; (2) Use of psychoactive substances, drug abuse and dependence; (3) People who have had allergies to the components of the intervention used in this study; (4) Women who are pregnant or breastfeeding, or those who need to prepare for pregnancy; (5) Secondary obesity; (6) Patients with diabetes (except pre-diabetes), heart disease, liver and kidney insufficiency, mental disease, systemic infectious disease, gastrointestinal disease; (7) There is a deformity or deformity of the limb that affects the measurement of height and weight; (8) Those with a history of alcohol abuse within 6 months prior to screening; (9) Those who have taken any weight loss measures or medication in the 6 months prior to screening; (10) Factors judged by other researchers to be unsuitable for participation in the experiment exist

Design outcomes

Primary

MeasureTime frame
Weight;Height;Waist circumference;Hip circumference;Skinfold thickness;Total body fat;Body fat rate;Body mass index, BMI;superconducting gravity gradiometer;

Secondary

MeasureTime frame
Serum interleukin-1;Adiponectin;Leptin;Total cholesterol, TC;Triglycerides, TG;Low-density lipoprotein cholesterol, LDL-C;High-density lipoprotein cholesterol, HDL-C;Blood glucose, BG;

Countries

China

Contacts

Public ContactHui Liang

College of Public Health, Medical College, Qingdao University

qdlianghui@126.com+86 186 1532 9686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026